Calcipotriene
Obesity-related Male Infertility
First Affiliated Hospital of Wenzhou Medical UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Obesity-related Male Infertility cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Tirzepatide First Affiliated Hospital of Wenzhou Medical University | Phase 2 | CCC |
Semaglutide First Affiliated Hospital of Wenzhou Medical University | Phase 2 | CCC |
Same molecule, other indications
Calcipotriene is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →